Checkpoint Therapeutics CEO James Oliviero's 2021 pay stays at $2.3M
Checkpoint Therapeutics reports 2021 executive compensation
By ExecPay News
Published: May 1, 2023
Checkpoint Therapeutics reported fiscal year 2021 executive compensation information on May 1, 2023.
In 2021, three executives at Checkpoint Therapeutics received on average a compensation package of $1.3M, a 15% decrease compared to previous year.
Average pay of disclosed executives at Checkpoint Therapeutics
James F. Oliviero III, Chief Executive Officer, received $2.3M in total, which is about the same as previous year. 62% of Oliviero's compensation, or $1.4M, was in stock awards. Oliviero also received $335K in non-equity incentive plan and $540K in salary.
Garrett Gray, Chief Financial Officer, received a compensation package of $748K. 53% of the compensation package, or $397K, was in stock awards.
William Garrett Gray, Chief Financial Officer, earned $748K in 2021, a 10% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on May 1, 2023.